The extent of residual prostate cancer in the surgical specimen following intensified neoadjuvant therapy for high-risk localized prostate cancer may predict metastatic recurrence. Residual ...

Thousands of men in the UK with advanced hormone-sensitive prostate cancer could soon be eligible for an oral therapy – Accord ... triptorelin, goserelin, and buserelin, and people men with ...

This strengthens the argument that PSA response to neoadjuvant therapy ... the dosing and duration of therapy currently favored for patients with high-risk prostate cancer are different from ...

For nearly eight in 10 men with prostate cancer, the disease is diagnosed early, in the local or regional stages. Most will be cured. Active surveillance, watchful waiting, radiation therapy and ...